# Study to Develop a Non-invasive Marker for Monitoring Myocardial Fibrosis

> **NCT01230918** · PHASE2 · TERMINATED · sponsor: **Ottawa Heart Institute Research Corporation** · enrollment: 120 (estimated)

## Conditions studied

- Hypertrophic Cardiomyopathy
- Acute Coronary Syndrome

## Interventions

- **RADIATION:** 99mTc-NC100692

## Key facts

- **NCT ID:** NCT01230918
- **Lead sponsor:** Ottawa Heart Institute Research Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-05
- **Primary completion:** 2017-04-20
- **Final completion:** 2017-04-20
- **Target enrollment:** 120 (ESTIMATED)
- **Why stopped:** Costs of study procedures has changed and escalated and became prohibitive.
- **Last updated:** 2017-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01230918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01230918, "Study to Develop a Non-invasive Marker for Monitoring Myocardial Fibrosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01230918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*